Cilcare is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. Cilcare External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss, and tinnitus. Cilcare is based in Montpellier and Paris (France), and Lexington (near Boston), MA (USA).

Authors

Lise Byelyayeva

Associate Director, Sales, Funding, & New Partnerships

Lise Byelyayeva brings extensive experience in the development of therapies for hearing disorders through her work at Cilcare, a French–U.S.-based biotech company specialized in auditory science,...

❮ ❯